3Glojnaric I, Casl MT, Simic D, et al. Serum amyloid A protein (SAA) in coloreetal carcinoma[J]. Clin Chem Lab Med, 2001, 39(2) : 129.
4Battistelli S, Stefanoni M, Lorenzi B, et al. Coagulation factor levels in non-metastatic colorectal cancer patients[J]. Int J Biol Markers, 2008, 23 ( 1 ) :36-41.
5Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual[M]. 6th ed. New York (NY): Springer-Verlag, 2002:113-124.
6Palumbo JS, Kombrinck KW, Drew AF, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells[J]. Blood, 2000, 96(10):3302-3309.
7Michaeli A, Finci-Yeheskel Z, Dishon S, et al. Serum amyloid A enhances plasminogen activation: implication for a role in colon cancer[J]. Biochem Biophys Res Comnmn, 2008, 368 (2) :368-373.
8Beer JH, Haeberlj A, Vogt A, et al. Coagulation markers predict survival in cancer patients [J]. Thromb Haemost, 2002, 88(5) :745-749.
9Katriina H, Shah E, Debbie AL. A systematic review of the association between circulating concentrations of c reactive protein and cancer[J]. J Epidemiol Community Health, 2007, 61(9) :824-832.
10Mitsuru I, Hitoshi N, Kazutoshi T, et al. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer[J]. Annals of Surg, 2007, 246(6) : 1047-1051.
